News
-
Antibodies against rheumatic diseases tested directly on patients 20 November 2024Leiden Professor of Translational Rheumatology Hans Ulrich Scherer has one foot in the clinic, where he helps patients, and the other in the lab, wher...
-
The Nobel Prize in Chemistry went to an AI model (and rightly so) 24 October 2024Not experiments and lab coats, but computers and artificial intelligence: this year's Nobel Prize in Chemistry went to the inventors of the groundbrea...
-
During the next pandemic, this mathematical model will speed up the search for treatment 09 September 2024Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer...
-
RARE-NL: LUMC joins consortium to find treatments for rare diseases 26 August 2024RARE-NL, a new collaboration between university hospitals, hopes to find treatments for rare diseases. Professor Teun van Gelder is representing the L...
-
Oncode Accelerator launched: patients at the centre of innovative cancer drug development 08 September 2023Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop ca...
-
In conversation with the head of the rodent facility 06 September 2023Before patients can take a pill, scientists often spend years in the lab developing and testing a candidate drug. That often includes experiments with...
-
Artificial intelligence as the co-pilot for drug discovery 23 May 2023There are more molecules that could conceivably be candidate drugs than there are stars in the universe. How can we ever efficiently identify those mo...
-
Horizon Europe grant for research into personalised treatment for high blood pressure 18 April 2023Professor Thomas Hankemeier and his international research team HYPERMARKER have received a 10m-euro grant from Horizon Europe and UK Research and Inn...
-
LUMC researchers: matching medication to DNA leads to 30% fewer side effects 03 February 2023According to an international group of researchers led by Leiden University Medical Center (LUMC), patients experience 30% fewer serious side effects ...
-
Cells with stress: predicting drug-induced liver and kidney damage 26 January 2023How can we prevent drug-induced liver and kidney damage? PhD candidates Marije Niemeijer and Lukas Wijaya investigated what happens in the cells durin...
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients' 06 October 2022'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge....
-
Developing drugs with artificial intelligence 07 February 2022Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that ca...
-
Drugging the undruggable: NWO Open Competition grant for Alireza Mashaghi 04 January 2022Finding structure in disordered proteins and developing drugs for undruggable diseases: it might sound like mission impossible, but pharmacologist Ali...
-
Adam Cohen receives Dr. Saal van Zwanenberg Honorary Prize 12 November 2021Professor of Clinical Pharmacology Adam Cohen from Leiden University received the prestigious Dr. Saal van Zwanenberg Honorary Prize on 12 November. T...
-
Pharma company Janssen expands premises on Leiden Bio Science Park 03 November 2021Pharma company Janssen has begun construction on a new office and lab building at the Leiden Bio Science Park. The first pile of the 13,500 square met...